HHS accelerates development of mRNA-based Zika vaccine

 

 

Dept. of Health & Human Services

HHS accelerates development of mRNA-based Zika vaccine

September 7, 2016

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced an $8.2 million contract award to Moderna Therapeutics of Cambridge, Massachusetts, to help speed the development of a novel vaccine to prevent the spread of the Zika virus. 

Read more about today's announcement

Tweet This

You are subscribed to HHS News Releases from the U.S. Department of Health & Human Services. Having trouble viewing this email? View it as a Web page.

All HHS News Releases are available in the HHS Newsroom. Visit the HHS Multimedia Gallery.

--

Preferences | Unsubscribe | Contact HHS

HHS on TwitterHHS on FacebookHHS on Google+